Article
Financial toxicity in BRCA1 and BRCA2 carriers.
Gynecologic oncology - 1 Mar 2023
Proussaloglou Ellie M, Rosenthal Alex E, Raker Christina A, Wilbur Jennifer Scalia, Stuckey Ashley R, Robison Katina M
Abstract excerpt
OBJECTIVE: Financial toxicity (FT), the cumulative financial burden experienced due to medical care, is a well-established adverse effect of healthcare. Patients with BRCA mutations have significantly increased cancer risks compared to non-affected individuals, requiring more frequent screenings and, at times, prophylactic surgery, increasing their risk for FT. Our primary aim in this study was to describe rates...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
